FIRST SIGN DRUG OF ABUSE SCREENING TEST

Enzyme Immunoassay, Amphetamine

W.H.P.M., INC.

The following data is part of a premarket notification filed by W.h.p.m., Inc. with the FDA for First Sign Drug Of Abuse Screening Test.

Pre-market Notification Details

Device IDK032575
510k NumberK032575
Device Name:FIRST SIGN DRUG OF ABUSE SCREENING TEST
ClassificationEnzyme Immunoassay, Amphetamine
Applicant W.H.P.M., INC. 163 CABOT ST. Beverly,  MA  01915
ContactFran White
CorrespondentFran White
W.H.P.M., INC. 163 CABOT ST. Beverly,  MA  01915
Product CodeDKZ  
Subsequent Product CodeDIO
Subsequent Product CodeDJC
Subsequent Product CodeDJG
Subsequent Product CodeDKE
Subsequent Product CodeLCM
CFR Regulation Number862.3100 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2003-08-20
Decision Date2004-05-19
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.